Cis-Urocanic acid
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C6H6N2O2 |
| Molar mass | 138.126 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
cis-Urocanic acid (cis-UCA) is a chemical compound produced by ultraviolet irradiation of trans-urocanic acid, a metabolite naturally formed in the body from histidine. cis-Urocanic acid is suspected of involvement in the development of skin cancer. It acts as an immunosuppressant through action as an agonist of the 5-HT2A receptor, and blocking this receptor has been shown to reduce cis-UCA mediated photocarcinogenesis. However the immunomodulatory effects of cis-UCA are complex and also involve other pathways, and at low levels it shows antiinflammatory actions and may be protective against UV damage in the cornea and retina. Measuring cis-UCA has been proposed as a sensitive method to detect sub-erythemal response to UVB, and thus a means to assess the UVR protection of suncreams.